1. GPCR/G Protein
  2. GCGR
  3. Dulaglutide

Dulaglutide  (Synonyms: LY2189265)

Cat. No.: HY-P0120 Purity: ≥90.0%
COA Handling Instructions

Dulaglutide (LY2189265) is a glucagon-like peptide-1 (GLP-1) receptor agonist. Dulaglutide can be uesd for the research of type 2 diabetes (T2D) .

For research use only. We do not sell to patients.

Custom Peptide Synthesis

Dulaglutide Chemical Structure

Dulaglutide Chemical Structure

CAS No. : 923950-08-7

Size Price Stock Quantity
1 mg USD 270 In-stock
5 mg USD 800 Get quote
10 mg   Get quote  
50 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Dulaglutide:

Top Publications Citing Use of Products

1 Publications Citing Use of MCE Dulaglutide

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Dulaglutide (LY2189265) is a glucagon-like peptide-1 (GLP-1) receptor agonist. Dulaglutide can be uesd for the research of type 2 diabetes (T2D) [1][2].

IC50 & Target

GLP-1 receptor[1]

In Vitro

Dulaglutide (50 nM and 100 nM; 24 h) ameliorates ox-LDL-induced oxidative stress and suppresses ox-LDL-induced mitochondrial dysfunction in human aortic endothelial cells (HAECs)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Human aortic endothelial cells (HAECs)
Concentration: 50 nM, 100 nM
Incubation Time: 24 hous
Result: Suppressed ox-LDL-induced reduction of cell viability and release of lactate dehydrogenase (LDH).
In Vivo

Dulaglutide (0, 0.05, 0.5, 1.5, or 5 mg/kg; s.c.; twice week, for 93 weeks) increases the incidence of thyroid C-cell hyperplasia and neoplasia in the rat carcinogenicity study[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Rats and Transgenic mice[1]
Dosage: 0, 0.05, 0.5, 1.5, or 5 mg/kg; 0, 0.3, 1, or 3 mg/kg
Administration: SC, twice week, for 93 weeks; SC, twice week, for 26 weeks
Result: Statistically increased diffuse C-cell hyperplasia and adenomas at >0.5 mg/kg.
Decreased Systemic exposures over time in mice.
Clinical Trial
CAS No.
Appearance

Liquid

Color

Colorless to light yellow

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Store at 4°C, do not freeze

Purity & Documentation

Purity: ≥90.0%

References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Dulaglutide
Cat. No.:
HY-P0120
Quantity:
MCE Japan Authorized Agent: